retatrutide news recency 3 People Are Already Taking This Unapproved New Weight-Loss Drug Medscape | Retatrutide, Eli Lilly's

Myth #1: GLP-1 Is Only for Diabetics Truth: GLP-1 Is for Weight Loss One of the most common GLP-1 misconceptions is that these medications are only for people with diabetes

Brand-name semaglutide, such as Ozempic and Wegovy, comes in prefilled injection pens made by the manufacturer, Novo Nordisk

If you are a diabetic and your HgbA1C is 9.4% (average blood sugar of 223), taking 15mg of Mounjaro (tirzepatide) once a week could lower your HgbA1C could be 7% (average glucose of 154)

Each cycle takes about 45 minutes, and we can treat multiple areas at once

A spokesperson for Eli Lilly, the maker of Mounjaro and Zepbound, said the company values efforts to make healthy living easier for everyone. When restaurants offer more menu options and flexible portion sizes they help empower diners, including those managing complex conditions like obesity and diabetes, to make healthier decisions and reduce food waste, the Lilly spokesperson said in a statement

The smaller the dose, the lower the odds of side effects, so microdosing can help someone feel good enough to stay on the medication